Xiidra
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Xiidra, covering 2016-07-11 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye [Phase 4]